Global Small Nucleic Acid Drugs for Hepatitis B Industry

2025-2031 Global Small Nucleic Acid Drugs for Hepatitis B Industry Research & Trends Analysis Report

Global Small Nucleic Acid Drugs for Hepatitis B Industry

2025-2031 Global Small Nucleic Acid Drugs for Hepatitis B Industry Research & Trends Analysis Report

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Market IntelliX Study, the global market for Small Nucleic Acid Drugs for Hepatitis B should grow from US$ 939 million in 2025 to US$ 1251 million by 2031, with a CAGR of 5.30% for the period of 2025 -2031.

Small Nucleic Acid Drugs for Hepatitis B Market Overview
Small Nucleic Acid Drugs for Hepatitis B are targeted anti-HBV therapeutics based on RNA interference or antisense oligonucleotide technology. They inhibit HBV replication by specifically silencing viral gene expression, effectively reducing hepatitis B surface antigen (HBsAg) and other viral protein levels. These drugs hold promise as a key component in achieving functional cure for HBV, with some candidates offering extended dosing intervals of several months. Currently, multiple pharmaceutical companies are advancing clinical trials to evaluate the potential of small nucleic acid drugs as monotherapy or in combination regimens.

Key Insights & Strategic Takeaways Driving Market Outlook

(1) Global Small Nucleic Acid Drugs for Hepatitis B market size (sales volume & revenue), history data from 2020 - 2025, and forecast data from {2025 to 2031.

(2) Global Small Nucleic Acid Drugs for Hepatitis B market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Small Nucleic Acid Drugs for Hepatitis B market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Small Nucleic Acid Drugs for Hepatitis B segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Small Nucleic Acid Drugs for Hepatitis B segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Small Nucleic Acid Drugs for Hepatitis B , capacity, production and trends.

(7) Small Nucleic Acid Drugs for Hepatitis B industry supply chain, upstream, midstream, and downstream analysis.

In-Depth Assessment of Market Segmentation by Geographic Region

➤ North America (United States, Canada, and Mexico)
➤ Europe (UK, Germany, France, Russia, and Italy)
➤ Asia-Pacific (China, Korea, Japan, India, and Southeast Asia)
➤ South America (Brazil, Colombia, Argentina, etc.)
➤ The Middle East and Africa (Saudi Arabia, UAE, Nigeria, Egypt, and South Africa)

Segmentation by Product Type: Analytical Breakdown and Market Relevance
This section presents a comprehensive analysis of the market based on product type, highlighting segment-wise performance indicators, emerging trends, and their strategic implications within the overall industry landscape.
  • Hospital
  • Clinic
  • Others

Market Segmentation by Application
Markets are categorized based on specific application areas, offering insight into usage trends and consumer preferences. This segmentation helps businesses tailor products, services, and strategies to align with diverse industry needs and customer demands.
  • Antisense Oligonucleotide (ASO) Drugs
  • siRNA Drugs

Market Segmentation by Key Players
This report examines the competitive landscape by categorizing market participants based on their roles, influence, and strategic positioning. Understanding player segmentation helps identify industry leaders, emerging competitors, and collaboration opportunities within the market.
  • Arbutus Biopharma
  • GSK
  • Ascletis
  • Ausperbio
  • Janssen Biotech (Johnson & Johnson)
  • Brii Biosciences
  • Barinthus Biotherapeutics
  • Suzhou Ribo Life Science

1 Market Overview

1.1 Product Overview and Scope of Small Nucleic Acid Drugs for Hepatitis B

1.2 Global Small Nucleic Acid Drugs for Hepatitis B Market Size and Forecast

1.3 China Small Nucleic Acid Drugs for Hepatitis B Market Size and Forecast

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Small Nucleic Acid Drugs for Hepatitis B Share in Global Market, 2020-2031

1.4.2 Small Nucleic Acid Drugs for Hepatitis B Market Size: China VS Global, 2020-2031

1.5 Small Nucleic Acid Drugs for Hepatitis B Market Dynamics

1.5.1 Small Nucleic Acid Drugs for Hepatitis B Market Drivers

1.5.2 Small Nucleic Acid Drugs for Hepatitis B Market Restraints

1.5.3 Small Nucleic Acid Drugs for Hepatitis B Industry Trends

1.5.4 Small Nucleic Acid Drugs for Hepatitis B Industry Policy

2 Competitive Landscape by Company

2.1 Global Small Nucleic Acid Drugs for Hepatitis B Revenue by Company, 2020-2025

2.2 Global Small Nucleic Acid Drugs for Hepatitis B Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.3 Global Small Nucleic Acid Drugs for Hepatitis B Concentration Ratio

2.4 Global Small Nucleic Acid Drugs for Hepatitis B Mergers & Acquisitions, Expansion Plans

2.5 Global Small Nucleic Acid Drugs for Hepatitis B Manufacturers Product Type

2.6 Global Geographic Distribution of Small Nucleic Acid Drugs for Hepatitis B Companies

3 China Competitive Situation by Company

3.1 China Small Nucleic Acid Drugs for Hepatitis B Revenue by Company, 2020-2025

3.2 China Small Nucleic Acid Drugs for Hepatitis B Small Nucleic Acid Drugs for Hepatitis B Participants, Market Position (Tier 1, Tier 2, and Tier 3)

3.3 China Small Nucleic Acid Drugs for Hepatitis B Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis

4.1 Small Nucleic Acid Drugs for Hepatitis B Industry Chain

4.2 Small Nucleic Acid Drugs for Hepatitis B Upstream Analysis

4.3 Small Nucleic Acid Drugs for Hepatitis B Midstream Analysis

4.4 Small Nucleic Acid Drugs for Hepatitis B Downstream Analysis

5 Sights by Type

5.1 Small Nucleic Acid Drugs for Hepatitis B Classification

5.1.1 Antisense Oligonucleotide (ASO) Drugs

5.1.2 siRNA Drugs

5.2 by Type, Global Small Nucleic Acid Drugs for Hepatitis B Market Size & CAGR, 2020 VS 2024 VS 2031

5.3 by Type, Global Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

6 Sights by Application

6.1 Small Nucleic Acid Drugs for Hepatitis B Segment by Application

6.1.1 Hospital

6.1.2 Clinic

6.1.3 Others

6.2 by Application, Global Small Nucleic Acid Drugs for Hepatitis B Market Size & CAGR, 2020 VS 2024 VS 2031

6.3 by Application, Global Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

7 Sights by Region

7.1 By Region, Global Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020 VS 2024 VS 2031

7.2 By Region, Global Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

7.3 North America

7.3.1 North America Small Nucleic Acid Drugs for Hepatitis B Market Size & Forecasts, 2020-2031

7.3.2 By Country, North America Small Nucleic Acid Drugs for Hepatitis B Market Size Market Share

7.4 Europe

7.4.1 Europe Small Nucleic Acid Drugs for Hepatitis B Market Size & Forecasts, 2020-2031

7.4.2 By Country, Europe Small Nucleic Acid Drugs for Hepatitis B Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Small Nucleic Acid Drugs for Hepatitis B Market Size & Forecasts, 2020-2031

7.5.2 By Country/Region, Asia Pacific Small Nucleic Acid Drugs for Hepatitis B Market Size Market Share

7.6 South America

7.6.1 South America Small Nucleic Acid Drugs for Hepatitis B Market Size & Forecasts, 2020-2031

7.6.2 By Country, South America Small Nucleic Acid Drugs for Hepatitis B Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Small Nucleic Acid Drugs for Hepatitis B Market Size & CAGR，2020 VS 2024 VS 2031

8.2 By Country, Global Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

8.3 United States

8.3.1 United States Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

8.3.2 By Company, United States Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024

8.3.3 by Type, United States Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.3.4 by Application, United States Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.4 Europe

8.4.1 Europe Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

8.4.2 By Company, Europe Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024

8.4.3 by Type, Europe Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.4.4 by Application, Europe Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.5 China

8.5.1 China Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

8.5.2 By Company, China Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024

8.5.3 by Type, China Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.5.4 by Application, China Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.6 Japan

8.6.1 Japan Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

8.6.2 By Company, Japan Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024

8.6.3 by Type, Japan Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.6.4 by Application, Japan Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

8.7.2 By Company, South Korea Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024

8.7.3 by Type, South Korea Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.7.4 by Application, South Korea Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

8.8.2 By Company, Southeast Asia Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024

8.8.3 by Type, Southeast Asia Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.8.4 by Application, Southeast Asia Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.9 India

8.9.1 India Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

8.9.2 By Company, India Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024

8.9.3 by Type, India Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.9.4 by Application, India Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.10 Middle East & Africa

8.10.1 Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Size, 2020-2031

8.10.2 By Company, Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024

8.10.3 by Type, Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

8.10.4 by Application, Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share, 2024 VS 2031

9 Company Profile

9.1 Arbutus Biopharma

9.1.1 Arbutus Biopharma Company Information, Head Office, Market Area, and Industry Position

9.1.2 Arbutus Biopharma Company Profile and Main Business

9.1.3 Arbutus Biopharma Small Nucleic Acid Drugs for Hepatitis B Models, Specifications, and Application

9.1.4 Arbutus Biopharma Small Nucleic Acid Drugs for Hepatitis B Revenue and Gross Margin, 2020-2025

9.1.5 Arbutus Biopharma Recent Developments

9.2 GSK

9.2.1 GSK Company Information, Head Office, Market Area, and Industry Position

9.2.2 GSK Company Profile and Main Business

9.2.3 GSK Small Nucleic Acid Drugs for Hepatitis B Models, Specifications, and Application

9.2.4 GSK Small Nucleic Acid Drugs for Hepatitis B Revenue and Gross Margin, 2020-2025

9.2.5 GSK Recent Developments

9.3 Ascletis

9.3.1 Ascletis Company Information, Head Office, Market Area, and Industry Position

9.3.2 Ascletis Company Profile and Main Business

9.3.3 Ascletis Small Nucleic Acid Drugs for Hepatitis B Models, Specifications, and Application

9.3.4 Ascletis Small Nucleic Acid Drugs for Hepatitis B Revenue and Gross Margin, 2020-2025

9.3.5 Ascletis Recent Developments

9.4 Ausperbio

9.4.1 Ausperbio Company Information, Head Office, Market Area, and Industry Position

9.4.2 Ausperbio Company Profile and Main Business

9.4.3 Ausperbio Small Nucleic Acid Drugs for Hepatitis B Models, Specifications, and Application

9.4.4 Ausperbio Small Nucleic Acid Drugs for Hepatitis B Revenue and Gross Margin, 2020-2025

9.4.5 Ausperbio Recent Developments

9.5 Janssen Biotech (Johnson & Johnson)

9.5.1 Janssen Biotech (Johnson & Johnson) Company Information, Head Office, Market Area, and Industry Position

9.5.2 Janssen Biotech (Johnson & Johnson) Company Profile and Main Business

9.5.3 Janssen Biotech (Johnson & Johnson) Small Nucleic Acid Drugs for Hepatitis B Models, Specifications, and Application

9.5.4 Janssen Biotech (Johnson & Johnson) Small Nucleic Acid Drugs for Hepatitis B Revenue and Gross Margin, 2020-2025

9.5.5 Janssen Biotech (Johnson & Johnson) Recent Developments

9.6 Brii Biosciences

9.6.1 Brii Biosciences Company Information, Head Office, Market Area, and Industry Position

9.6.2 Brii Biosciences Company Profile and Main Business

9.6.3 Brii Biosciences Small Nucleic Acid Drugs for Hepatitis B Models, Specifications, and Application

9.6.4 Brii Biosciences Small Nucleic Acid Drugs for Hepatitis B Revenue and Gross Margin, 2020-2025

9.6.5 Brii Biosciences Recent Developments

9.7 Barinthus Biotherapeutics

9.7.1 Barinthus Biotherapeutics Company Information, Head Office, Market Area, and Industry Position

9.7.2 Barinthus Biotherapeutics Company Profile and Main Business

9.7.3 Barinthus Biotherapeutics Small Nucleic Acid Drugs for Hepatitis B Models, Specifications, and Application

9.7.4 Barinthus Biotherapeutics Small Nucleic Acid Drugs for Hepatitis B Revenue and Gross Margin, 2020-2025

9.7.5 Barinthus Biotherapeutics Recent Developments

9.8 Suzhou Ribo Life Science

9.8.1 Suzhou Ribo Life Science Company Information, Head Office, Market Area, and Industry Position

9.8.2 Suzhou Ribo Life Science Company Profile and Main Business

9.8.3 Suzhou Ribo Life Science Small Nucleic Acid Drugs for Hepatitis B Models, Specifications, and Application

9.8.4 Suzhou Ribo Life Science Small Nucleic Acid Drugs for Hepatitis B Revenue and Gross Margin, 2020-2025

9.8.5 Suzhou Ribo Life Science Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Small Nucleic Acid Drugs for Hepatitis B Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Small Nucleic Acid Drugs for Hepatitis B Market trending toward high growth trajectories?
A dynamic process in the Small Nucleic Acid Drugs for Hepatitis B Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Arbutus Biopharma GSK Ascletis Ausperbio Janssen Biotech (Johnson & Johnson) Brii Biosciences Barinthus Biotherapeutics Suzhou Ribo Life Science.
How competitive is the Small Nucleic Acid Drugs for Hepatitis B Market going to be?
The strategic moves of the Small Nucleic Acid Drugs for Hepatitis B Market players such as Arbutus Biopharma GSK Ascletis Ausperbio Janssen Biotech (Johnson & Johnson) Brii Biosciences Barinthus Biotherapeutics Suzhou Ribo Life Science, and others clearly highlight consumer-centric strategies that use technology to improve customer experience.
What important business segments are segregated by application types in the latest edition of the Small Nucleic Acid Drugs for Hepatitis B Market?
The key business segments in the Small Nucleic Acid Drugs for Hepatitis B Market are segregated by applications [Antisense Oligonucleotide (ASO) Drugs siRNA Drugs] and types [Hospital Clinic Others].
What is the estimated size & growth rate of the Small Nucleic Acid Drugs for Hepatitis B Market?
In recent years, the Small Nucleic Acid Drugs for Hepatitis B Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
In the current situation, what value does the Small Nucleic Acid Drugs for Hepatitis B Market have?
The value of the Small Nucleic Acid Drugs for Hepatitis B Market is estimated to be USD XXX million.
What are the top priorities for the growth of the Small Nucleic Acid Drugs for Hepatitis B Market?
In this highly competitive and rapidly evolving Small Nucleic Acid Drugs for Hepatitis B Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.